Drug class
Polydisperse oligonucleotide mixture; endothelial-protective and profibrinolytic agent
Mechanism of action
The mechanism of action is not fully elucidated. Defibrotide has been shown to modulate endothelial-cell activation and has profibrinolytic, antithrombotic and anti-inflammatory effects, with relative sparing of systemic coagulation parameters. The exact molecular target responsible for clinical benefit remains uncertain.
General use cases
- Treatment of severe hepatic veno-occlusive disease (VOD), also called sinusoidal obstruction syndrome (SOS), with renal or pulmonary dysfunction following haematopoietic stem-cell transplantation (HSCT) in adults and children; specialist hospital use
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
